Search Results 1081-1090 of 17824 for monoclonal antibody

1. Ph1b/2 Dose-Escalation Study of Entinostat With Pembrolizumab in NSCLC With Expansion Cohorts in NSCLC, Melanoma, and Colorectal Cancer - Mayo Clinic

   ... antibody Patients in Expansion Phase, Cohorts 2 and 3; Previously ... Prior anti-cancer monoclonal antibody (mAb) within 4 weeks prior to baseline ...

2. A Study to Evaluate the Safety and Immunological Effect of Pembrolizumab in Resectable or Borderline Resectable Pancreatic Cancer - Mayo Clinic

   Has had a prior monoclonal antibody within 4 weeks prior to study Day 1 or ... antibody (including ipilimumab or any other antibody or drug ...

3. COVID19 Immunology and Omics Study - Clinical Trials

   Individuals who are recieving a monoclonal antibody infusion. Participating Mayo Clinic locations. Study statuses change often. Please contact the study team ...

4. MS or not MS? Mayo Clinic Neuroimmunology Lab answers the question

   The AQP4 antibody, discovered at Mayo Clinic in 2004, was the first biomarker associated with inflammatory demyelinating diseases that could be used to ...

5. Mayo Clinic Q&A - Dr. Gregory Poland - COVID-19 Update Audio...

   It significantly negated the value of some of our monoclonal antibodies. So ... So, the theory had been that these allergic reactions are mediated by an antibody ...

6. A Phase 1/2, First-in-Human, Open Label, Dose Escalation Study Of A CSP Targeting Functional Antibody in Solid Tumors - Mayo Clinic

   A Phase 1/2, First-in-Human, Open Label, Dose Escalation Study Of A CSP Targeting Functional Antibody in Solid Tumors. Print details. Share; Facebook · Twitter.

7. Cyclophosphamide, Carfilzomib, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed Active Multiple Myeloma - Mayo Clinic

   ... monoclonal antibody therapy; Palliative radiation therapy is permitted if clinically indicated and not indicative of progressive disease. Participating Mayo ...

8. Rabies immune globulin (intramuscular route) - Side effects & uses - Mayo Clinic

   Rabies immune globulin is used together with rabies vaccine to prevent infection caused by the rabies virus. It works by giving your body the antibodies it ...

9. Hepatocellular Carcinoma (HCC) Clinical Trials - Mayo Clinic Research

   The purpose of this study is to assess the efficacy and safety of tiragolumab, an anti-TIGIT monoclonal antibody, when administered in combination with ...

10. A Study Of IBI363 In Subjects With Advanced Solid Malignancies - Mayo Clinic

    ... monoclonal antibody (mAb) within 4 weeks prior to first dose 3. Received live vaccines within 28 days prior to first administration of the study drug or ...